← Every company
Cencora Inc Lobbying
What Cencora Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
COR on carbonthat →Disclosed spend
$2.5M
across every filing on file
Filings
19
Years covered
1
Firms retained
4
What it lobbies about
Health IssuesTaxation/Internal Revenue CodeMedicare/MedicaidPharmacyDefenseTrade (domestic/foreign)
19 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20261st Quarter (Jan 1 - Mar 31) | CENCORA, INC.Medicare/MedicaidPharmacy | $1.2M |
| 20262nd Quarter (Apr 1 - June 30) | CENCORA, INC.Medicare/MedicaidPharmacy | $510K |
| 20262nd Quarter (Apr 1 - June 30) | THE DUBERSTEIN GROUP INC.Trade (domestic/foreign)Health Issues | $75K |
| 20261st Quarter (Jan 1 - Mar 31) | THE DUBERSTEIN GROUP INC.Trade (domestic/foreign)Health Issues | $75K |
| 20261st Quarter (Jan 1 - Mar 31) | HARBINGER STRATEGIES, LLCHealth IssuesTaxation/Internal Revenue Code | $60K |
| 20262nd Quarter (Apr 1 - June 30) | KOUNTOUPES DENHAM CARR & REID, LLCTaxation/Internal Revenue CodeMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | BROWNSTEIN HYATT FARBER SCHRECK, LLPHealth IssuesPharmacy | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | KOUNTOUPES DENHAM CARR & REID, LLCHealth IssuesPharmacy | $60K |
| 20262nd Quarter (Apr 1 - June 30) | HARBINGER STRATEGIES, LLCHealth IssuesTaxation/Internal Revenue Code | $60K |
| 20262nd Quarter (Apr 1 - June 30) | BROWNSTEIN HYATT FARBER SCHRECK, LLPPharmacyHealth Issues | $60K |
| 20262nd Quarter (Apr 1 - June 30) | BALLARD SPAHR LLPMedicare/MedicaidPharmacy | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | BALLARD SPAHR LLPMedicare/MedicaidPharmacy | $50K |
| 20262nd Quarter (Apr 1 - June 30) | TCH GROUP, LLCHealth Issues | $30K |
| 20262nd Quarter (Apr 1 - June 30) | INLET STRATEGIESMedicare/MedicaidHealth Issues | $30K |
| 20261st Quarter (Jan 1 - Mar 31) | INLET STRATEGIESHealth IssuesTaxation/Internal Revenue Code | $30K |
| 20261st Quarter (Jan 1 - Mar 31) | MONUMENT ADVOCACYHealth Issues | $30K |
| 20262nd Quarter (Apr 1 - June 30) | MONUMENT ADVOCACYHealth Issues | $30K |
| 20261st Quarter (Jan 1 - Mar 31) | TCH GROUP, LLCHealth Issues | $30K |
| 20261st Quarter (Jan 1 - Mar 31) | MONUMENT ADVOCACYHealth Issues | — |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on COR
Company overviewEverything on COR in one place, with the price.SEC filingsWhat COR's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat COR's own officers and directors buy and sell.Planned salesSales COR insiders have filed notice of.Who owns itEvery manager reporting a position in COR.Funds holding itWhich funds and ETFs hold COR, and how big a bet.Who lobbies for itThe lobbyists on COR's account, and who they worked for.Federal contractsWhat federal agencies pay COR.